CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective Study-Reference-Cited by-同舟云学术

CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective Study

Published:2000-11 Issue:1 Volume:166 Page:201-203
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Arai Hiroyuki,Ishiguro Koichi,Ohno Hideto,Moriyama Michiko,Itoh Nobuo,Okamura Nobuyuki,Matsui Toshifumi,Morikawa Yu-ichi,Horikawa Etsuo,Kohno Hideki,Sasaki Hidetada,Imahori Kazutomo

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference14 articles.

1. Diagnostic and Statistical Manuals of Mental Disorders,1987

2. No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia;Arai;Neurosci. Lett.,1999

3. Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease;Bi;Exp. Neurol.,1999

4. Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease;Galasko;Neurology,1997

5. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease;Gomez-Isla;J. Neurosci.,1996

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of plasma candidate biomarkers of Alzheimer’s Disease;Neurologia i Neurochirurgia Polska;2024-08-28

2. Investigating the Potential Impact of Air Pollution on Alzheimer’s Disease and the Utility of Multidimensional Imaging for Early Detection;ACS Omega;2024-02-15

3. CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease;International Journal of Molecular Sciences;2023-05-19

4. Research and Prospect of Blood Biomarkers for Alzheimer’s Disease;Hans Journal of Biomedicine;2023

5. Exploration of salient risk factors involved in mild cognitive impairment;European Journal of Neuroscience;2022-04-17